Clinical Trials Directory

Trials / Unknown

UnknownNCT00031122

Study of Genetic Risk Factors for Spina Bifida and Anencephaly

The Spina Bifida Research Resource

Status
Unknown
Phase
Study type
Observational
Enrollment
1,100 (estimated)
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · NIH
Sex
All
Age
Healthy volunteers
Accepted

Summary

The purpose of this study is to describe the genetic contribution to the neural tube defects spina bifida (SB) and anencephaly (A), which includes identifying patients, defining the roles of certain genes, and studying gene-environment interactions.

Detailed description

The terms spina bifida and anencephaly include a range of developmental malformations that result from abnormal or incomplete closure of the neural tube. Despite advances in treatment and prenatal detection, these conditions remain as one of the most common and serious groups of birth defects. Spina bifida is associated with both increased mortality and morbidity, and anencephaly is always fatal. The occurrence of these conditions has a profound influence on affected individuals and their families and important public health implications. The etiology of NTDs has been of considerable interest for several decades. They are known to be etiologically heterogeneous and to occur in association with chromosome abnormalities, teratogenic exposures, and occasionally as part of single gene disorders. However, a specific causative agent cannot be identified in the vast majority of affected individuals. The etiology of NTDs in these "non-syndromic" patients is believed to be complex and to involve both genetic and environmental risk factors. Using a comprehensive research program, this study will evaluate the potential genetic determinants of SB and anencephaly in a large, well-characterized sample. The family constellation used in this study consists of the proband (individual with an NTD - SB or A) and the proband's biologic parents and maternal grandparents. Blood or saliva samples are obtained from individuals and their families. Genomic DNA from all study participants is prepared from the samples, and genetic loci are evaluated. The proband, or his/her parents, complete a study questionnaire to obtain family history and epidemiologic information.

Conditions

Interventions

TypeNameDescription
OTHERNo InterventionThere is no intervention in this study

Timeline

Start date
2000-09-01
Primary completion
2011-09-01
Completion
2012-09-01
First posted
2002-02-27
Last updated
2010-10-05

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00031122. Inclusion in this directory is not an endorsement.